Skip to main content
Article

Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma

Hareth NahiCenter for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, SE-14183 Huddinge, SwedenMichael ChrobokCenter for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, SE-14183 Huddinge, SwedenStephan MeinkeCenter for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, SE-14183 Huddinge, SwedenCharlotte GranCenter for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, SE-14183 Huddinge, SwedenNicole MarquardtCenter for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, SE-14183 Huddinge, SwedenGabriel AframCenter for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, SE-14183 Huddinge, SwedenTolga SütlüCenter for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, SE-14183 Huddinge, SwedenMari GilljamCenter for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, SE-14183 Huddinge, SwedenBirgitta StellanCenter for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, SE-14183 Huddinge, SwedenArnika Kathleen WagnerCenter for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, SE-14183 Huddinge, SwedenPontus BlombergVecura, Department of Laboratory Medicine, Karolinska Institutet, SE-14186 Stockholm, SwedenPer-Henrik HolmqvistVecura, Karolinska Cell Therapy Center, Karolinska University Hospital, SE-14186 Stockholm, SwedenLilian Walther–JallowDepartment of Clinical Science, Intervention and Technology, Karolinska Institutet, SE-14183 Huddinge, SwedenKarin MellströmJohan LiwingCharlotte GustafssonCenter for Hematology and Regenerative Medicine, Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institutet, SE-14183 Huddinge, SwedenRobert MånssonCenter for Hematology and Regenerative Medicine, Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institutet, SE-14183 Huddinge, SwedenMonika KlimkowskaDepartment of Clinical Pathology and Cytology, Karolinska University Hospital, SE-14186 Huddinge, SwedenGösta GahrtonCenter for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, SE-14183 Huddinge, SwedenJohan LundCenter for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, SE-14183 Huddinge, SwedenPer LjungmanDepartment of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, SE-14186 Huddinge, SwedenHans‐Gustaf LjunggrenCenter for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, SE-14183 Huddinge, SwedenEvren AliciCenter for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, SE-14183 Huddinge, Sweden
2022en
ABI

Abstract

activated and expanded autologous NK cells in patients with multiple myeloma (MM) post-autologous stem cell transplantation. Infused NK cells were detected in circulation up to 4 weeks after the last infusion. Elevations in plasma granzyme B levels were observed following each consecutive NK cell infusion. Moreover, increased granzyme B levels were detected in bone marrow 4 weeks after the last infusion. All measurable patients had objective, detectable responses after NK cell infusions in terms of reduction in M-component and/or minimal residual disease. The present study demonstrates that autologous NK cell-based immunotherapy is feasible in a setting of MM consolidation therapy. It opens up the possibility for usage of autologous NK cells in clinical settings where patients are not readily eligible for allogeneic NK cell-based immunotherapies.

Identifiers

Citations and references

Cited by 20 references